Passer au contenu principal

Subventions financées

Filtrer par:
Effacer les filtres
Filtrer par:

815 résultats trouvés

Enabling Neuroscience research Approaches for Brain, feeLings and Emotions (ENABLE): An Platform for Clinical Trials in Mood Disorders

Mood disorders such as depression and bipolar disorder affect over 350 million people around the world.


TYPE DE SUBVENTION
Subventions de la plate-forme
Domaine de recherche
Santé mentale
Province
Ontario
DATE DE DÉBUT
2022

Mind Over Matter Magazine (Volume 15)


TYPE DE SUBVENTION
Subventions pour l'application des connaissances
Domaine de recherche
Traduction des connaissances
Concours
Autres
Province
Ontario
DATE DE DÉBUT
2022

Enhancing Supports for Autistic Post-Secondary Students at the University of Calgary

Autistic individuals are disproportionately under-represented in post-secondary institutions, with only 35% of students with autism pursuing post-secondary education.


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Développement neurologique
Concours
Prix KBHN pour les chercheurs en début de carrière et les mentors
Province
Alberta
DATE DE DÉBUT
2022

The development of an online peer navigation intervention for youth with neurodevelopmental disabilities

Background: Transition from the pediatric to adult health care system is a multi-faceted process that should include medical and psychosocial considerations.


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Développement neurologique
Concours
Prix KBHN pour les chercheurs en début de carrière et les mentors
Province
Ontario
DATE DE DÉBUT
2022

Community implementation and evaluation of acceptance and commitment training (ACT) for family caregivers

Family caregivers of people with neurodevelopmental disabilities (NDDs) often experience stress and mental health difficulties (e.g., anxiety, depression)


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Développement neurologique
Concours
Fonds d'investissement stratégique KBHN
Province
Ontario
DATE DE DÉBUT
2022

Investigating TDP-43 palmitoylation as a therapeutic target to lower protein aggregation

TDP-43 (transactive response DNA-binding protein 43) is one of the few genes highly associated with ALS (amyotrophic lateral sclerosis).


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Neurodégénérescence
Province
Ontario
DATE DE DÉBUT
2022

Personalized medicine for Bipolar disorder: clinical lithium response as a guide to mode of action and biomarker discovery using human neurons and biofluids

Bipolar Disorder (BD) is a chronic psychiatric illness, ranking in the top 10 causes of disability and mortality worldwide, due to suicide and cardiovascular death.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Santé mentale
Province
Québec
DATE DE DÉBUT
2022

Precision in Space and Time: Brain State-Dependent Stimulation Using Real-Time EEG and TMS

The goal of this project is to develop new principles to treat brain disease and investigate brain function using non-invasive neurostimulation, without the side-effects of drugs.


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Santé mentale
Concours
Les futurs leaders de la recherche sur le cerveau au Canada
Province
Ontario
DATE DE DÉBUT
2022

Sex bias in autism spectrum disorders: Examining how sexual differentiation leads to divergent neurodevelopment and social behaviour

Males are 4X more likely than females to develop Autism Spectrum Disorder (ASD), suggesting that the biology of sex development contributes to the risk of developing this neurodevelopmental condition.


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Développement neurologique
Concours
Les futurs leaders de la recherche sur le cerveau au Canada
Province
Terre-Neuve et Labrador
DATE DE DÉBUT
2022

Targeting GRP78 palmitoylation in glioblastomas

Glioblastoma multiforme (GBM) the most common form of brain cancer in adults with very low survival of only 15 months with less than 5% of patients surviving more than 5 years. Surgery, chemotherapy, and radiation are the treatments currently used but recurrence is very common, often with tumors that are resistant to treatment.


TYPE DE SUBVENTION
Subventions pour le renforcement des capacités
Domaine de recherche
Le cancer
Concours
Les futurs leaders de la recherche sur le cerveau au Canada
Province
Ontario
DATE DE DÉBUT
2022